Gilead Sciences Inc (LTS:0QYQ)
$ 64.235 -0.18 (-0.28%) Market Cap: 80.16 Bil Enterprise Value: 100.63 Bil PE Ratio: 178.72 PB Ratio: 4.57 GF Score: 70/100

Gilead Sciences Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 25, 2021 / 06:40PM GMT
Release Date Price: $63.64 (+0.10%)
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst

Good afternoon, everybody, and welcome to this afternoon session of our Global Healthcare Conference. I'm delighted to welcome our next company, Gilead Sciences, I presume known to everybody on the call. From Gilead, we're joined by Johanna Mercier, Chief Commercial Officer; and Andy Dickinson, Chief Financial Officer.

Johanna and Andy, thank you for joining our conference today and appearing on screen at least from California.

Johanna Mercier
Gilead Sciences, Inc. - Chief Commercial Officer

Thanks for having us.

Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO

Thank you. Thanks for having us.

Questions & Answers

Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst

So our format today is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot